This is the twelfth conference focusing on issues related to antiepileptic drug (AED) development from preclinical discoveries through clinical evaluations. New innovations in therapy are under siege from several directions, including complex regulatory requirements, increased payer expectations, and issues in data quality. Yet, we are still in need of novel therapies for patients with epilepsy. At each AED conference, we re-evaluate strategies to ensure continued advancement. There is always the opportunity to learn from the past as we move into the future. This symposium will bring together representatives from academia, industry, the NIH, and the FDA to review what has been learned and to discuss strategies to enhance AED development.
这是第十二次会议，关注相关的抗癫痫药物（AED）的发展问题，从临床前发现通过临床评估。在治疗的新的创新是从几个方向围攻下，包括复杂的监管要求，提高了纳税人的期望，以及数据质量的问题。然而，我们仍然需要癫痫患者的新疗法。在每个AED会议上，我们重新评估策略，以确保持续的进步。总是有机会从过去中学习，因为我们进入未来。本次研讨会将汇集来自学术界，产业界，美国国家卫生研究院，美国FDA审查了什么教训，并讨论策略，以加强AED的发展。

Fixed LinkedIn profile import issue.